Novel Nondietary Therapies for Celiac Disease.
Study Goal
The researchers aimed to evaluate the limitations of a gluten-free diet (GFD) for managing Celiac Disease (CeD) and explore the need for non-dietary therapies.
Results Summary
The study found that a GFD alone is insufficient to fully control symptoms or prevent mucosal damage in CeD patients, highlighting the need for adjunct or alternative non-dietary therapies. Long-term complications persist despite adherence to a GFD.
Population
Individuals with Celiac Disease (CeD), a genetically predisposed population.
Effective Dosage
Not specified
Duration
Not specified
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
gluten-free diet (GFD) | no change | symptoms and mucosal damage | patients with Celiac Disease (CeD) | null | is not sufficient to control symptoms and prevent mucosal damage | #1 |
non-dietary therapies | null | management of CeD | patients with Celiac Disease (CeD) | null | could serve as an adjunct to the GFD but eventually may replace it | #2 |
Celiac Disease (CeD) is defined as a chronic small intestinal immune-mediated enteropathy that is precipitated by exposure to dietary gluten in genetically predisposed individuals. CeD is one of the most common autoimmune disorders affecting around 1% of the population worldwide. Currently, the only acceptable treatment for CeD is strict, lifelong adherence to a gluten-free diet (GFD) which can often present a challenging task. A GFD alone is not sufficient to control symptoms and prevent mucosal damage that can result from unintentional gluten exposure. Moreover, long-term complications can occur in many patients. Consequently, there is an unmet need for non-dietary therapies for the management of CeD. Such therapies could serve as an adjunct to the GFD but eventually may replace it. This review will focus on and discuss non-dietary therapies currently in clinical development for the management of CeD. METHODOLOGY: We searched clinicaltrials.gov and PubMed to extract articles about celiac disease. We used keywords including, but not limited to, "celiac disease," "non-dietary," "therapeutics," "pathophysiology," "Endopeptidases," "tight junction modulators," "vaccine," and "Nexvax2". We focused mainly on articles that conducted pathophysiologic and therapeutic research in human trials.